{"id":"https://openalex.org/W2885961944","doi":"https://doi.org/10.1007/bf00257121","title":"The bioavailability of oral intermediate-dose methotrexate: Effect of dose subdivision, formulation, and timing in the chemotherapy cycle","display_name":"The bioavailability of oral intermediate-dose methotrexate: Effect of dose subdivision, formulation, and timing in the chemotherapy cycle","alternate_titles":[],"publication_year":1984,"publication_date":"1984-08-01","ids":{"openalex":"https://openalex.org/W2885961944","doi":"https://doi.org/10.1007/bf00257121","mag":"2885961944","pmid":"https://pubmed.ncbi.nlm.nih.gov/6467500"},"language":"en","primary_location":{"id":"doi:10.1007/bf00257121","doi":"https://doi.org/10.1007/bf00257121","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00257121","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2885961944"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110159396","display_name":"V.J. Harvey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V.J. Harvey","raw_affiliation_strings":["Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's Hospital and Hackney Hospital, EC1A 7BE, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's Hospital and Hackney Hospital, EC1A 7BE, London, England","institution_ids":["https://openalex.org/I1307195382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103439714","display_name":"Maurice L. Slevin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.L. Slevin","raw_affiliation_strings":["Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's Hospital and Hackney Hospital, EC1A 7BE, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's Hospital and Hackney Hospital, EC1A 7BE, London, England","institution_ids":["https://openalex.org/I1307195382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111807972","display_name":"R. Woollard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R.C. Woollard","raw_affiliation_strings":["Department of Clinical Pharmacology, St Bartholomew's Hospital, EC1A 7BE, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St Bartholomew's Hospital, EC1A 7BE, London, England","institution_ids":["https://openalex.org/I1307195382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073036990","display_name":"A. E. Johnston","orcid":"https://orcid.org/0000-0001-5787-2270","observed_orcids":["https://orcid.org/0000-0001-5787-2270"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Johnston","raw_affiliation_strings":["Department of Clinical Pharmacology, St Bartholomew's Hospital, EC1A 7BE, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St Bartholomew's Hospital, EC1A 7BE, London, England","institution_ids":["https://openalex.org/I1307195382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103584960","display_name":"M. J. Barnett","orcid":"https://orcid.org/0009-0006-5520-0298","observed_orcids":["https://orcid.org/0009-0006-5520-0298"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.J. Barnett","raw_affiliation_strings":["Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's Hospital and Hackney Hospital, EC1A 7BE, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's Hospital and Hackney Hospital, EC1A 7BE, London, England","institution_ids":["https://openalex.org/I1307195382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108441549","display_name":"Peter F.M. Wrigley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P.F.M. Wrigley","raw_affiliation_strings":["Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's Hospital and Hackney Hospital, EC1A 7BE, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial Cancer Research Fund Department of Medical Oncology, St Bartholomew's Hospital and Hackney Hospital, EC1A 7BE, London, England","institution_ids":["https://openalex.org/I1307195382"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012013682","display_name":"Paul Turner","orcid":"https://orcid.org/0000-0002-8131-5412","observed_orcids":["https://orcid.org/0000-0002-8131-5412"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Turner","raw_affiliation_strings":["Department of Clinical Pharmacology, St Bartholomew's Hospital, EC1A 7BE, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St Bartholomew's Hospital, EC1A 7BE, London, England","institution_ids":["https://openalex.org/I1307195382"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1307195382"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":2.7054,"has_fulltext":false,"cited_by_count":16,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88301282,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"13","issue":"2","first_page":"91","last_page":"94"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.482699990272522,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.482699990272522,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2290000021457672,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.05079999938607216,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8870000243186951},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9789999723434448},{"id":"https://openalex.org/keywords/intermediate-dose-methotrexate","display_name":"intermediate-dose methotrexate","score":0.8939999938011169},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.671999990940094},{"id":"https://openalex.org/keywords/timing-of-drug-administration","display_name":"timing of drug administration","score":0.5},{"id":"https://openalex.org/keywords/oral-versus-intravenous-administration","display_name":"oral versus intravenous administration","score":0.6650000214576721},{"id":"https://openalex.org/keywords/drug-absorption","display_name":"drug absorption","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9483447670936584},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.8781719207763672},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6866528987884521},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6507861614227295},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6130379438400269},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5649136304855347},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.5640267133712769},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5543686747550964},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2763858437538147},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.052690863609313965},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf00257121","doi":"https://doi.org/10.1007/bf00257121","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00257121","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:6467500","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6467500","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W328857071","https://openalex.org/W1523358411","https://openalex.org/W1558085296","https://openalex.org/W1559344958","https://openalex.org/W1949042228","https://openalex.org/W1984654807","https://openalex.org/W2000442910","https://openalex.org/W2023073276","https://openalex.org/W2023284543","https://openalex.org/W2034478957","https://openalex.org/W2057568639","https://openalex.org/W2070525678","https://openalex.org/W2070781226","https://openalex.org/W2095029217","https://openalex.org/W2103790960","https://openalex.org/W2108109304","https://openalex.org/W2278220001","https://openalex.org/W2408506002","https://openalex.org/W4236314225"],"related_works":["https://openalex.org/W4302111747","https://openalex.org/W2023284543","https://openalex.org/W42745244","https://openalex.org/W2023073276","https://openalex.org/W2333271364","https://openalex.org/W1990486388","https://openalex.org/W2320427031","https://openalex.org/W1871949656"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2885961944","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2018-08-22T00:00:00"}
